These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15209899)

  • 1. What has universal leucodepletion given us: evidence from clinical trials?
    van de Watering L
    Vox Sang; 2004 Jul; 87 Suppl 2():139-42. PubMed ID: 15209899
    [No Abstract]   [Full Text] [Related]  

  • 2. Leucodepletion and immune response mechanisms.
    Semple JW
    Vox Sang; 2004 Jul; 87 Suppl 2():136-8. PubMed ID: 15209898
    [No Abstract]   [Full Text] [Related]  

  • 3. Universal leucodepletion: an overview of some unresolved issues and the highlights of lessons learned.
    Seghatchian J
    Transfus Apher Sci; 2003 Oct; 29(2):105-17. PubMed ID: 12941346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal leukocyte reduction: Is it appropriate medical practice or not?
    Angelbeck JH; Ortolano GA
    J Infus Nurs; 2005; 28(4):273-81. PubMed ID: 16106211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the improvement of leucodepletion performance of the Haemonetics MCS+ for production of leucodepleted platelet concentrate.
    Seghatchian J; Beard MJ; Krailadsiri P
    Platelets; 2001 Aug; 12(5):298-301. PubMed ID: 11487382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of leukoreduktion of blood components.
    Brand A; van de Watering LM; Claas FH
    Vox Sang; 2000; 78 Suppl 2():227-9. PubMed ID: 10938958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Production of leucocyte-deficient preserved blood for prospective graft recipients].
    Goldmann SF; Glavind-Kristensen S; Heiss F; Kissmeyer-Nielsen F
    Munch Med Wochenschr; 1971 Mar; 113(10):358-60. PubMed ID: 5107863
    [No Abstract]   [Full Text] [Related]  

  • 8. Leucodepletion, bacterial testing and pathogen removal update and position for Scotland: April 2001.
    Prowse CV
    Transfus Apher Sci; 2001 Dec; 25(3):217-8. PubMed ID: 11846149
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolation of CD4+CD25+ regulatory T cells for clinical trials.
    Hoffmann P; Boeld TJ; Eder R; Albrecht J; Doser K; Piseshka B; Dada A; Niemand C; Assenmacher M; Orsó E; Andreesen R; Holler E; Edinger M
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):267-74. PubMed ID: 16503495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucodepletion, bacterial contamination and viral inactivation: a Portuguese blood centre experience.
    Vasconcelos E
    Transfus Apher Sci; 2001 Dec; 25(3):215-6. PubMed ID: 11846148
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukocyte counting during process control of leukoreduced blood components.
    Dzik WH
    Vox Sang; 2000; 78 Suppl 2():223-6. PubMed ID: 10938957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of two types of leukocyte removal filters on transfusion dependent thalassaemics.
    Jamal R; Mazeni NR; Hussin H
    Malays J Pathol; 2000 Dec; 22(2):79-83. PubMed ID: 16329539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helinx technology for inactivation of infectious pathogens and leukocytes in labile blood components: from theory to clinical application.
    Corash L
    Transfus Apher Sci; 2001 Dec; 25(3):179-81. PubMed ID: 11846134
    [No Abstract]   [Full Text] [Related]  

  • 14. Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies?
    Gidron A; Verma A; Doyle M; Boggio L; Evens A; Gordon L; Singhal S; Tallman M; Williams S; Winter J; Mehta J
    Bone Marrow Transplant; 2005 Feb; 35(3):243-6. PubMed ID: 15580281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of leucodepletion on leucocyte activation, pulmonary inflammation and respiratory index in surgery for coronary revascularisation: a prospective randomised study.
    Alexiou C; Tang AA; Sheppard SV; Smith DC; Gibbs R; Livesey SA; Monro JL; Haw MP
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):294-300. PubMed ID: 15296886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucodepletion (LD) trends and preferred approaches.
    Rowe G
    Transfus Apher Sci; 2001 Dec; 25(3):219-20. PubMed ID: 11846150
    [No Abstract]   [Full Text] [Related]  

  • 17. Dual reduction in the immunologic and infectious complications of transfusion by filtration/removal of leukocytes from donor blood soon after collection.
    Rawal BD; Davis RE; Busch MP; Vyas GN
    Transfus Med Rev; 1990 Oct; 4(4 Suppl 1):36-41. PubMed ID: 2134639
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous improvements in national leucodepletion outcome and potential cause of leucodepletion failure.
    Seghatchian J; Beckman N
    Transfus Apher Sci; 2001 Dec; 25(3):221-4. PubMed ID: 11846151
    [No Abstract]   [Full Text] [Related]  

  • 19. Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study.
    Schonewille H; Brand A
    Br J Haematol; 2005 Apr; 129(1):151-6. PubMed ID: 15801967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood stem cell collection in pediatric patients: feasibility of leukapheresis under anesthesia in uncompliant small children with solid tumors.
    Ravagnani F; Coluccia P; Notti P; Arienti F; Bompadre A; Avella M; Bozzi F; Barzanò E; Podda M; Pupa S; Luksch R
    J Clin Apher; 2006 Jul; 21(2):85-91. PubMed ID: 16035098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.